BPC-157 TB-500 Blend 20mg – Lyophilized Peptide Research Product

Product Overview

The BPC-157 TB-500 Blend 20mg from Global Peptides Lab is a lyophilized peptide product featuring two distinct research compounds: BPC-157 and TB-500. Presented in a 7 mL (6R) glass vial, this product is supplied as a dry powder and has not been reconstituted.

Researchers evaluating peptide materials often need clear product specifications, transparent batch identification, and access to relevant analytical testing information. This product listing brings those details together to help customers understand the stated composition, physical form, packaging, and available quality-control results.

The supplied batch report, dated June 8, 2026, includes reported purity, individual peptide measurements, a TFA test, sterility testing, and endotoxin screening. These results relate to the identified batch and should be reviewed alongside the original laboratory documentation.

Product highlights

• Product: BPC-157 and TB-500 peptide blend
• Marketed quantity: 20 mg
• Physical form: Lyophilized powder
• Packaging: 7 mL (6R) vial
• Reconstitution status: Not reconstituted
• Reported purity: Approximately 99%
• TFA test: Not detected
• Sterility test: Pass
• Endotoxins (LPS): Pass
• Batch reference: BPTB06261020j

What Is a BPC-157 and TB-500 Peptide Blend?

BPC-157 and TB-500 are distinct peptide-related research compounds that have been discussed in scientific literature and experimental research contexts. Although they are often mentioned together in the research peptide market, they have different identities and should not be treated as interchangeable substances.

BPC-157 is a synthetic peptide associated with experimental investigations into biological processes. TB-500 is a name used commercially for a thymosin beta-4-related peptide product; the exact molecular identity and composition should be verified from the supplier’s documentation rather than assumed from the product name alone.

A combined peptide research product places both named compounds in the same preparation. For laboratory documentation, it is important to establish the identity of each component, its measured quantity, and the analytical methods used to characterize the material.

The presence of two compounds in a single vial does not establish that the combination has a particular biological effect. Any scientific conclusions require appropriate evidence and cannot be inferred from the product name alone.

Product Specifications

The BPC-157 TB-500 Blend 20mg is described as a lyophilized powder supplied in a vial rather than a ready-made liquid preparation.

Packaging and physical characteristics

• Product form: Lyophilized powder.
• Vial type: Glass vial.
• Vial size: 7 mL (6R), as supplied in the product specifications.
• Preparation status: Not reconstituted.
• Nominal product quantity: 20 mg, subject to confirmation against the batch documentation.

Lyophilization is a process used to remove water from a material through freezing and drying under controlled conditions. It is commonly used in the preparation of laboratory materials, although the presence of a lyophilized form does not by itself establish a product’s stability, shelf life, or suitability for a particular experiment.

The vial capacity is a packaging specification and should not be confused with the total mass of peptide in the vial.

Batch-Specific Testing and Quality Information

Transparent testing information helps customers evaluate what a product report states and identify which results relate to a particular batch.

The supplied BPC-157 and TB-500 test information identifies batch BPTB06261020j and gives a test date of June 8, 2026. The reported results are summarized below.

Test parameter	Reported result
Purity	Approximately 99%
BPC-157 measured amount	11.60 mg
TB-500 measured amount	11.64 mg
TFA	Not detected
Sterility	Pass
Endotoxins (LPS)	Pass
Batch number	BPTB06261020j
Test date	June 8, 2026

These values are transcribed from the supplied product information. Customers should consult the original test report for the analytical methods, acceptance criteria, laboratory identity, and other supporting details.

A reported purity percentage is not the same as a sterility result. Likewise, a passing endotoxin test and a result of no detected TFA describe different test parameters. None of these individual results, on its own, proves that a product is suitable for injection, human consumption, or clinical use.

Quantity discrepancy to resolve: The report lists 11.60 mg of BPC-157 and 11.64 mg of TB-500, which add up to 23.24 mg. Because this differs from the advertised 20 mg quantity, the supplier should reconcile the nominal product specification with the reported measurements before confirming the total blend quantity on the product label.

Understanding Purity, Sterility, Endotoxins and TFA

Purity testing

Purity testing assesses the proportion of the material attributed to the target compound under a specified analytical method. The reported purity of approximately 99% should be interpreted according to the method and documentation provided by the testing laboratory. Purity alone does not establish identity, biological activity, or suitability for human use.

Sterility testing

Sterility testing evaluates whether specified microorganisms are detected under the conditions of the test. The supplied report records a passing result. The meaning and scope of that result depend on the test method, sampling, and laboratory procedures.

Endotoxin testing

Endotoxins, also known as lipopolysaccharides (LPS), are bacterial components that can cause biological responses. The supplied report records a passing endotoxin result. The numerical result, test sensitivity, and acceptance threshold should be reviewed in the original documentation where available.

TFA testing

Trifluoroacetic acid (TFA) may be associated with peptide manufacturing and purification processes. The supplied report states that TFA was not detected. This statement should be understood within the detection limits and methodology of the test performed.

Storage and Handling Information

Follow the supplier’s documented storage conditions and the relevant laboratory’s procedures for handling research materials. The information supplied for this listing does not specify a validated storage temperature, expiration date, or stability period, so these details should not be assumed.

Keep the material in its original, appropriately labeled container and protect it from unauthorized access. Avoid exposure to environmental conditions outside the supplier’s documented specifications. Refer to the accompanying documentation for applicable handling, transport, and disposal requirements.

This listing does not provide reconstitution instructions, dosage guidance, injection directions, or recommendations for use in people or animals.

Frequently Asked Questions

What is the BPC-157 TB-500 Blend 20mg?

It is a product marketed as a combination of BPC-157 and TB-500 for research purposes. It is supplied as a lyophilized powder in a vial and is described as not reconstituted.

What is the physical form of the product?

The product is supplied as a dry, lyophilized powder in a 7 mL (6R) vial. The vial size refers to the container specification, not the amount of peptide it holds.

What do the supplied batch test results report?

The supplied information reports approximately 99% purity, BPC-157 at 11.60 mg, TB-500 at 11.64 mg, no detected TFA, and passing sterility and endotoxin tests. The original report should be consulted to verify the methods and results.

Does the test report confirm a total quantity of 20 mg?

Not as currently transcribed. The two reported component measurements total 23.24 mg, which differs from the advertised 20 mg. This discrepancy requires clarification from the supplier before the total quantity can be confirmed.

Is this product approved for human use?

The product is presented as a research material, not an approved medicine. The listing makes no claim that it is authorized for human use, and laboratory test results do not establish clinical safety or effectiveness.

Is the product supplied as a liquid?

No. According to the supplied specifications, it is supplied as a lyophilized powder and has not been reconstituted.

Global Peptides Lab: Product Information and Transparency

Global Peptides Lab aims to present research-product information in a clear, structured format, including product identity, packaging details, batch references, and available test results.

When evaluating any research material, customers should review the relevant documentation, verify the identity and quantity of each component, and distinguish laboratory quality-control findings from evidence of biological activity or clinical suitability.

The BPC-157 TB-500 Blend 20mg listing is intended to provide a straightforward reference for the stated product characteristics and supplied batch information. Confirm the quantity discrepancy and consult the original testing documentation before relying on the listed measurements.

Research use only. Not for human or veterinary use. This product is not represented as a treatment, cure, or preventive measure for any medical condition.